• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用寡脱氧核苷酸加白细胞介素-2可改善脾边缘区淋巴瘤的细胞遗传学分析。

Employment of oligodeoxynucleotide plus interleukin-2 improves cytogenetic analysis in splenic marginal zone lymphoma.

作者信息

Bardi Antonella, Cavazzini Francesco, Rigolin Gian Matteo, Tammiso Elisa, Volta Eleonora, Pezzolo Elisa, Formigaro Luca, Sofritti Olga, Daghia Giulia, Ambrosio Cristina, Rizzotto Lara, Abass Awad E, D'Auria Fiorella, Musto Pellegrino, Cuneo Antonio

机构信息

Section of Haematology, Department of Bio-Medical Sciences and Advanced Therapies, University of Ferrara, Ferrara, Italy.

出版信息

J Biomed Biotechnol. 2011;2011:691493. doi: 10.1155/2011/691493. Epub 2011 May 21.

DOI:10.1155/2011/691493
PMID:21629757
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3100609/
Abstract

To compare the efficiency of novel mitogenic agents and traditional mitosis inductors, 18 patients with splenic marginal zone lymphoma (SMZL) were studied. Three cultures using oligodeoxynucleotide (ODN) plus interleukin-2 (IL-2), or TPA, or LPS were setup in each patient. Seventeen/18 cases with ODN + IL2 had moderate/good proliferation (94, 4%) as compared with 10/18 cases with TPA and LPS (55%) (P = .015); 14/18 (77, 7%) cases with ODN + IL2 had sufficient good quality of banding as compared with 8/18 cases (44, 4%) with TPA and LPS. The karyotype could be defined from ODN + IL2-stimulated cultures in all 18 patients, 14 of whom (77, 7%) had a cytogenetic aberration, whereas clonal aberrations could be documented in 9 and in 3 cases by stimulation with LPS and TPA, respectively. Recurrent chromosome aberrations in our series were represented by aberrations of chromosome 14q in 5 patients, by trisomy 12 and 7q deletion in 4 cases each, and by abnormalities involving 11q and 13q in two cases each. These findings show that stimulation with ODN + IL2 offers more mitotic figures of better quality and results in an increased rate of clonal aberrations in SMZL, making this method ideal for prospective studies aiming at the definition of the prognostic impact of cytogenetic aberrations in this disorder.

摘要

为比较新型促有丝分裂剂与传统有丝分裂诱导剂的效率,对18例脾边缘区淋巴瘤(SMZL)患者进行了研究。为每位患者设置了三种培养体系,分别使用寡脱氧核苷酸(ODN)加白细胞介素-2(IL-2)、佛波酯(TPA)或脂多糖(LPS)。与使用TPA和LPS的10/18例患者(55%)相比,17/18例使用ODN + IL2的患者具有中度/良好增殖(94.4%)(P = 0.015);与使用TPA和LPS的8/18例患者(44.4%)相比,14/18例(77.7%)使用ODN + IL2的患者具有足够良好的带型质量。在所有18例患者中,均可从ODN + IL2刺激的培养物中确定核型,其中14例(77.7%)存在细胞遗传学异常,而通过LPS和TPA刺激,分别有9例和3例可记录到克隆性异常。在我们的系列研究中,复发性染色体异常表现为:5例患者存在14q染色体异常,4例患者各有12号染色体三体和7q缺失,2例患者各有涉及11q和13q的异常。这些发现表明,ODN + IL2刺激可提供更多质量更好的有丝分裂图像,并导致SMZL中克隆性异常率增加,使得该方法非常适合旨在明确细胞遗传学异常对该疾病预后影响的前瞻性研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4326/3100609/ec597a1b4684/JBB2011-691493.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4326/3100609/3261556ee58f/JBB2011-691493.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4326/3100609/2982831d1d75/JBB2011-691493.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4326/3100609/58d7da79b71c/JBB2011-691493.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4326/3100609/7d0e5ec9efda/JBB2011-691493.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4326/3100609/ec597a1b4684/JBB2011-691493.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4326/3100609/3261556ee58f/JBB2011-691493.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4326/3100609/2982831d1d75/JBB2011-691493.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4326/3100609/58d7da79b71c/JBB2011-691493.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4326/3100609/7d0e5ec9efda/JBB2011-691493.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4326/3100609/ec597a1b4684/JBB2011-691493.005.jpg

相似文献

1
Employment of oligodeoxynucleotide plus interleukin-2 improves cytogenetic analysis in splenic marginal zone lymphoma.使用寡脱氧核苷酸加白细胞介素-2可改善脾边缘区淋巴瘤的细胞遗传学分析。
J Biomed Biotechnol. 2011;2011:691493. doi: 10.1155/2011/691493. Epub 2011 May 21.
2
Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group.330 例脾脏边缘区 B 细胞淋巴瘤的细胞遗传学异常及其预后价值:脾脏 B 细胞淋巴瘤研究组的一项多中心研究。
Blood. 2010 Sep 2;116(9):1479-88. doi: 10.1182/blood-2010-02-267476. Epub 2010 May 17.
3
Idelalisib and Rituximab in 17p Deletion-Positive Splenic Marginal Zone Lymphoma.17p 缺失阳性脾边缘区淋巴瘤患者采用伊德拉利昔单抗联合利妥昔单抗治疗。
J Natl Compr Canc Netw. 2018 Mar;16(3):230-233. doi: 10.6004/jnccn.2017.7034.
4
Splenic marginal zone lymphoma: characterization of 7q deletion and its value in diagnosis.脾脏边缘区淋巴瘤:7q 缺失的特征及其在诊断中的价值。
J Pathol. 2010 Mar;220(4):461-74. doi: 10.1002/path.2665.
5
Clonal cytogenetic abnormalities are predictor in developing non-Hodgkin lymphomas?克隆性细胞遗传学异常是发展为非霍奇金淋巴瘤的预测指标吗?
Exp Mol Pathol. 2017 Feb;102(1):146-155. doi: 10.1016/j.yexmp.2017.01.007. Epub 2017 Jan 11.
6
CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases.CD5 表达鉴定出具有更高淋巴细胞增多的脾边缘区淋巴瘤亚群:24 例临床病理、细胞遗传学和分子研究。
Haematologica. 2010 Apr;95(4):604-12. doi: 10.3324/haematol.2009.011049. Epub 2009 Dec 16.
7
Uncommon cytogenetic findings in a case of splenic marginal zone lymphoma with aggressive clinical course.
Cancer Genet Cytogenet. 2004 Jan 15;148(2):133-6. doi: 10.1016/s0165-4608(03)00242-5.
8
Splenic marginal zone B-cell lymphomas: two cytogenetic subtypes, one with gain of 3q and the other with loss of 7q.脾边缘区B细胞淋巴瘤:两种细胞遗传学亚型,一种为3q获得,另一种为7q缺失。
Haematologica. 2001 Jan;86(1):71-7.
9
Genetic and phenotypic attributes of splenic marginal zone lymphoma.脾脏边缘区淋巴瘤的遗传和表型特征。
Blood. 2022 Feb 3;139(5):732-747. doi: 10.1182/blood.2021012386.
10
FOXP1 status in splenic marginal zone lymphoma: a fluorescence in situ hybridization and immunohistochemistry approach.
Histol Histopathol. 2009 Nov;24(11):1399-404. doi: 10.14670/HH-24.1399.

引用本文的文献

1
Prognostic correlation of NOTCH1 and SF3B1 mutations with chromosomal abnormalities in chronic lymphocytic leukemia patients.NOTCH1 和 SF3B1 突变与慢性淋巴细胞白血病患者染色体异常的预后相关性。
Cancer Rep (Hoboken). 2023 Mar;6(3):e1757. doi: 10.1002/cnr2.1757. Epub 2022 Nov 21.
2
Biological significance and prognostic/predictive impact of complex karyotype in chronic lymphocytic leukemia.慢性淋巴细胞白血病复杂核型的生物学意义及预后/预测影响
Oncotarget. 2018 Sep 28;9(76):34398-34412. doi: 10.18632/oncotarget.26146.
3
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness.

本文引用的文献

1
Stimulation of chronic lymphocytic leukemia cells with CpG oligodeoxynucleotide gives consistent karyotypic results among laboratories: a CLL Research Consortium (CRC) Study.用CpG寡脱氧核苷酸刺激慢性淋巴细胞白血病细胞在各实验室间产生一致的核型结果:一项慢性淋巴细胞白血病研究联盟(CRC)的研究
Cancer Genet Cytogenet. 2010 Dec;203(2):134-40. doi: 10.1016/j.cancergencyto.2010.07.128.
2
Biological and clinical characterization of recurrent 14q deletions in CLL and other mature B-cell neoplasms.14q 缺失在 CLL 和其他成熟 B 细胞肿瘤中的生物学和临床特征分析。
Br J Haematol. 2010 Oct;151(1):25-36. doi: 10.1111/j.1365-2141.2010.08299.x. Epub 2010 Jul 22.
3
一项针对高危慢性淋巴细胞白血病的广泛分子细胞遗传学特征分析确定了核型异常和TP53破坏是预后和化疗难治性的预测指标。
Oncotarget. 2017 Apr 25;8(17):28008-28020. doi: 10.18632/oncotarget.15883.
4
Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations.慢性淋巴细胞白血病诊断时的广泛二代测序分析:临床与生物学相关性
J Hematol Oncol. 2016 Sep 15;9(1):88. doi: 10.1186/s13045-016-0320-z.
Toward a comprehensive prognostic scoring system in chronic lymphocytic leukemia based on a combination of genetic parameters.
基于遗传参数组合的慢性淋巴细胞白血病综合预后评分系统。
Genes Chromosomes Cancer. 2010 Sep;49(9):851-9. doi: 10.1002/gcc.20794.
4
Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group.330 例脾脏边缘区 B 细胞淋巴瘤的细胞遗传学异常及其预后价值:脾脏 B 细胞淋巴瘤研究组的一项多中心研究。
Blood. 2010 Sep 2;116(9):1479-88. doi: 10.1182/blood-2010-02-267476. Epub 2010 May 17.
5
Splenic marginal zone lymphoma: characterization of 7q deletion and its value in diagnosis.脾脏边缘区淋巴瘤:7q 缺失的特征及其在诊断中的价值。
J Pathol. 2010 Mar;220(4):461-74. doi: 10.1002/path.2665.
6
Array comparative genomic hybridization identifies genetic regions associated with outcome in aggressive diffuse large B-cell lymphomas.阵列比较基因组杂交技术可识别与侵袭性弥漫性大B细胞淋巴瘤预后相关的基因区域。
Cancer. 2009 Aug 15;115(16):3728-37. doi: 10.1002/cncr.24430.
7
Splenic marginal zone lymphomas are characterized by loss of interstitial regions of chromosome 7q, 7q31.32 and 7q36.2 that include the protection of telomere 1 (POT1) and sonic hedgehog (SHH) genes.脾脏边缘区淋巴瘤的特征是染色体 7q、7q31.32 和 7q36.2 区域的缺失,这些区域包括端粒 1(POT1)和 Sonic Hedgehog(SHH)基因的保护。
Br J Haematol. 2008 Jun;142(2):216-26. doi: 10.1111/j.1365-2141.2008.07176.x. Epub 2008 May 19.
8
Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria.脾边缘区淋巴瘤:关于修订诊断、分期及治疗标准的建议
Leukemia. 2008 Mar;22(3):487-95. doi: 10.1038/sj.leu.2405068. Epub 2007 Dec 20.
9
Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV(H) status and immunophenotyping.慢性淋巴细胞白血病的全面基因特征分析:一项对506例病例进行染色体显带分析、间期荧光原位杂交、IgV(H)状态及免疫表型分析的研究
Leukemia. 2007 Dec;21(12):2442-51. doi: 10.1038/sj.leu.2404935. Epub 2007 Sep 6.
10
Genetics and risk-stratified approach to therapy in chronic lymphocytic leukemia.慢性淋巴细胞白血病的遗传学与风险分层治疗方法
Best Pract Res Clin Haematol. 2007 Sep;20(3):439-53. doi: 10.1016/j.beha.2007.02.006.